Thomas WALTER

199
Documents

Publications

Publications

Surgical planning of small intestine neuroendocrine tumors: the concept of mesenteric tumor deposits

Romain L’huillier , Gilles Poncet , Arnaud Pasquer , Thomas Walter , Catherine Lombard-Bohas et al.
Endocrine Oncology, 2025, 5 (1), ⟨10.1530/EO-24-0056⟩
Article dans une revue hal-04987278 v1

Cold snaring vs. standard forceps biopsy in sampling colorectal cancer: a comparative case report

Simona Agazzi , Eukene Rojo , Elena de Cristofaro , Jérôme Rivory , Thomas Walter et al.
Endoscopy, 2025, 57 (S 01), pp.E190-E191. ⟨10.1055/a-2535-1929⟩
Article dans une revue hal-04987279 v1

Basic science and translational implications of current knowledge on neuroendocrine tumors

Lynnette Fernandez-Cuesta , Nicolas Alcala , Emilie Mathian , Jules Derks , Chrissie Thirlwell et al.
The Journal of clinical investigation, 2025, 135 (5), pp.960-971. ⟨10.1172/JCI186702⟩
Article dans une revue hal-04987277 v1
Image document

Comprehensive molecular portrait reveals genetic diversity and distinct molecular subtypes of small intestinal neuroendocrine tumors

Céline Patte , Roxane Pommier , Anthony Ferrari , Felicia Fei-Lei Chung , Maria Ouzounova et al.
Nature Communications, 2025, 16 (1), pp.2197. ⟨10.1038/s41467-025-57305-8⟩
Article dans une revue hal-04987274 v1
Image document

A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217)

Jaume Capdevila , Virginia Pubul , Urbano Anido , Thomas Walter , Javier Molina-Cerrillo et al.
BMC Cancer, 2025, 25 (1), pp.613. ⟨10.1186/s12885-025-13941-3⟩
Article dans une revue hal-05022367 v1
Image document

PFMG2025–integrating genomic medicine into the national healthcare system in France

Caroline Abadie , Aldja Abderrahmane , Ouarda Abdous , Carine Abel , Oanez Ackermann et al.
The Lancet Regional Health - Europe, 2025, 50, ⟨10.1016/j.lanepe.2024.101183⟩
Article dans une revue hal-04988732 v1
Image document

Histopronostic factors in superficial colorectal adenocarcinomas treated by endoscopy: reproducibility and impact of immunohistochemistry and digital pathology

Guillaume Pontarollo , Maxime Bonjour , Thomas Walter , Mathieu Pioche , Pierre-Marie Lavrut et al.
Virchows Archiv, 2024, ⟨10.1007/s00428-023-03722-3⟩
Article dans une revue hal-04490334 v1
Image document

Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort study

Margaux Mekkan-Bouv Hez , Lea Derbey , Louis de Mestier , Lorenzo D , Thomas Walter et al.
International Journal of Surgery, 2024, ⟨10.1097/js9.0000000000001382⟩
Article dans une revue hal-04575949 v1

Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O 6 -Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET)

Thomas Walter , Thierry Lecomte , Julien Hadoux , Patricia Niccoli , Léa Saban-Roche et al.
Journal of Clinical Oncology, 2024, ⟨10.1200/JCO.23.02724⟩
Article dans une revue hal-04886197 v1
Image document

Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project

É. Mathian , Y. Drouet , A. Sexton-Oates , M.G. Papotti , G. Pelosi et al.
ESMO Open, 2024, 9 (6), pp.103591. ⟨10.1016/j.esmoop.2024.103591⟩
Article dans une revue hal-04655442 v1
Image document

Duodenal neuroendocrine tumor successfully removed by endoscopic submucosal dissection with adaptative traction device

Elena de Cristofaro , Jérôme Rivory , Thomas Walter , Jérémie Jacques , Timothée Wallenhorst et al.
Endoscopy, 2024, 56 (S 01), pp.E317-E318. ⟨10.1055/a-2291-9448⟩
Article dans une revue hal-04647923 v1

Outcome on Mesenteric Mass Response of Small-Intestinal Neuroendocrine Tumors Treated by 177 Lu-DOTATATE Peptide Receptor Radionuclide Therapy: The MesenLuth Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network

Laure Al Mansour , Louis de Mestier , Magalie Haissaguerre , Pauline Afchain , Julien Hadoux et al.
Journal of Nuclear Medicine, 2024, 65 (2), pp.258-263. ⟨10.2967/jnumed.123.266063⟩
Article dans une revue hal-04465202 v1

Systematic Resection of the Visible Scar After Incomplete Endoscopic Resection of Rectal Neuroendocrine Tumors

Loïc Cheminel , Alexandru Lupu , Timothée Wallenhorst , Vincent Lepilliez , Sarah Leblanc et al.
The American Journal of Gastroenterology, 2024, 119 (2), pp.378-381. ⟨10.14309/ajg.0000000000002516⟩
Article dans une revue hal-04435460 v1

Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan–RENATEN Network

Aurelien Fosse , Julien Hadoux , Paul Girot , Amandine Beron , Pauline Afchain et al.
Journal of Nuclear Medicine, 2024, pp.jnumed.123.267363. ⟨10.2967/jnumed.123.267363⟩
Article dans une revue hal-04675518 v1

Serum and urinary 5-hydroxyindolacetic acid, serotonin, chromogranin A, and NT-proBNP for the detection of carcinoid heart disease

Antoine Lecoeur , Rita-Maria Sfeir , Laura Gerard , Myriam Souifi , Johanna Damour et al.
European Journal of Endocrinology, 2024, 191 (6), pp.570-578. ⟨10.1093/ejendo/lvae150⟩
Article dans une revue hal-04886186 v1

French guidelines from the GTE, AFCE and ENDOCAN-RENATEN (Groupe d’étude des Tumeurs Endocrines/Association Francophone de Chirurgie Endocrinienne/Reseau national de prise en charge des tumeurs endocrines) for the screening, diagnosis and management of Multiple Endocrine Neoplasia Type 1

Pierre Goudet , Guillaume Cadiot , Anne Barlier , Eric Baudin , Françoise Borson-Chazot et al.
Annales d'Endocrinologie = Annals of Endocrinology, 2024, 85 (1), pp.2-19. ⟨10.1016/j.ando.2023.09.003⟩
Article dans une revue hal-04490329 v1

Neuropilin 2 and soluble neuropilin 2 in neuroendocrine neoplasms

Laura Gerard , Céline Patte , Laurence Chardon , Valérie Hervieu , Léa Payen et al.
Endocrine-Related Cancer, 2024, 31 (6), ⟨10.1530/ERC-24-0052⟩
Article dans une revue hal-04638761 v1
Image document

Beyond MEN1, When to Think About MEN4? Retrospective Study on 5600 Patients in the French Population and Literature Review

Benjamin Chevalier , Lucie Coppin , Pauline Romanet , Thomas Cuny , Jean-Christophe Maïza et al.
Journal of Clinical Endocrinology and Metabolism, 2024, ⟨10.1210/clinem/dgae055⟩
Article dans une revue hal-04522637 v1

Interference With VIP to Distinguish Between Real and False VIPoma: National Study From the French Endocrine Tumors Group

Benjamin Chevalier , Delphine Bonnet , Come Lepage , Marine Perrier , Françoise Borson-Chazot et al.
Journal of the Endocrine Society, 2024, 8 (7), pp.188-194. ⟨10.1210/jendso/bvae102⟩
Article dans une revue hal-04934196 v1

Health care resource use and costs among patients with carcinoid syndrome in France: Analysis of the National Health Insurance Database

Marine Perrier , Charbel Mouawad , Delphine Gueguen , Benoit Thomé , Maryse Lapeyre-Mestre et al.
Clinics and Research in Hepatology and Gastroenterology, 2023, 47 (7), pp.102177. ⟨10.1016/j.clinre.2023.102177⟩
Article dans une revue hal-04489768 v1

ASO Visual Abstract: The Need of Centralization for Small Intestinal Neuroendocrine Tumor Surgery—A Cohort Study from the GTE-Endocan-RENATEN Network, the CentralChirSINET Study

Maroin Kalifi , Sophie Deguelte , Matthieu Faron , Pauline Afchain , Louis de Mestier et al.
Annals of Surgical Oncology, 2023, 31 (2), pp.1144-1145. ⟨10.1245/s10434-023-14382-7⟩
Article dans une revue hal-04490348 v1

Surgery of primary lung carcinoid tumors at metastatic stage: A national study from the French Group of Endocrine Tumors ( GTE ) and ENDOCAN‐RENATEN network

Lucie Duponchelle , Eric Baudin , Fabien Subtil , Christine Do Cao , Eric Dansin et al.
Journal of Neuroendocrinology, 2023, 35 (10), ⟨10.1111/jne.13331⟩
Article dans une revue hal-04517673 v1

Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network

Marine Perrier , Mathias Brugel , Laura Gerard , Bernard Goichot , Astrid Lièvre et al.
European Journal of Endocrinology, 2023, European Journal of Endocrinology, 189 (6), pp.575-583. ⟨10.1093/ejendo/lvad157⟩
Article dans une revue hal-04338301 v1

EUS-guided radiofrequency ablation of pancreatic neoplasm is far from being the new criterion standard

Milenea Muzzolini , Thomas Walter , Sébastien Gaujoux
Gastrointestinal Endoscopy, 2023, 98 (6), pp.1039-1040. ⟨10.1016/j.gie.2023.07.023⟩
Article dans une revue hal-04490396 v1
Image document

A practical proposal on treatment sequencing of metastatic well-differentiated neuroendocrine tumours

Thomas Walter , Marine Perrier , Jean-Yves Scoazec
Therapeutic Advances in Medical Oncology, 2023, 15, pp.175883592311710. ⟨10.1177/17588359231171041⟩
Article dans une revue (article de synthèse) hal-04489754 v1
Image document

Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle?

Antoine Coupier , Yves Gallien , Olivier Boillot , Thomas Walter , Olivier Guillaud et al.
Clinical Transplantation, 2023, 37 (1), pp.e14841. ⟨10.1111/ctr.14841⟩
Article dans une revue hal-04183824 v1
Image document

From netrin‐1‐targeted <scp>SPECT</scp> / <scp>CT</scp> to internal radiotherapy for management of advanced solid tumors

David Kryza , Jennifer Wischhusen , Mathieu Richaud , Maëva Hervieu , Jacqueline Sidi Boumedine et al.
EMBO Molecular Medicine, 2023, 15, ⟨10.15252/emmm.202216732⟩
Article dans une revue hal-04107206 v1

OPERA: perception of information in patients with gastroenteropancreatic neuroendocrine tumors on lanreotide autogel

Vincent Hautefeuille , Thomas Walter , Christine Do Cao , Romain Coriat , Sophie Dominguez et al.
European Journal of Endocrinology, 2023, 189 (2), pp.281-289. ⟨10.1093/ejendo/lvad094⟩
Article dans une revue hal-04489831 v1

COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study

Nicola Fazio , Lorenzo Gervaso , Thorvardur Halfdanarson , Mohamad Sonbol , Rachel Eiring et al.
Endocrine-Related Cancer, 2023, 30 (6), ⟨10.1530/erc-22-0395⟩
Article dans une revue hal-04489844 v1

European Neuroendocrine Tumor Society ( ENETS ) 2023 guidance paper for appendiceal neuroendocrine tumours ( aNET )

Gregory Kaltsas , Thomas Walter , Ulrich Knigge , Christos Toumpanakis , Ana Santos et al.
Journal of Neuroendocrinology, 2023, 35 (10), ⟨10.1111/jne.13332⟩
Article dans une revue hal-04489826 v1

Recurrence after surgical resection of nonmetastatic sporadic gastrinoma: Which prognostic factors and surgical procedure?

Léa Robin , Alain Sauvanet , Thomas Walter , Haythem Najah , Massimo Falconi et al.
Surgery, 2023, 173 (5), pp.1144-1152. ⟨10.1016/j.surg.2022.12.030⟩
Article dans une revue hal-04489743 v1

High Tumor Uptake on 18 F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network

Ophélie de Rycke , Marine Perrier , Éric Ouvrard , Clément Mennetrey , Choaib Lachachi et al.
Journal of Nuclear Medicine, 2023, 64 (11), pp.1699-1705. ⟨10.2967/jnumed.123.265584⟩
Article dans une revue hal-04490390 v1
Image document

Adjuvant chemotherapy benefit according to T and N stage in small bowel adenocarcinoma: a large retrospective multicenter study

Aziz Zaanan , Julie Henriques , Anthony Turpin , Sylvain Manfredi , Romain Coriat et al.
JNCI Cancer Spectrum, 2023, 7 (5), pkad064. ⟨10.1093/jncics/pkad064⟩
Article dans une revue hal-04282951 v1
Image document

The Need for Centralization for Small Intestinal Neuroendocrine Tumor Surgery: A Cohort Study from the GTE-Endocan-RENATEN Network, the CentralChirSINET Study

Maroin Kalifi , Sophie Deguelte , Matthieu Faron , Pauline Afchain , Louis de Mestier et al.
Annals of Surgical Oncology, 2023, 30 (13), pp.8528-8541. ⟨10.1245/s10434-023-14276-8⟩
Article dans une revue hal-04490380 v1

Carcinoid heart disease in patients with midgut neuroendocrine tumours

Clémence Delhomme , Thomas Walter , Dimitri Arangalage , Gaspard Suc , Olivia Hentic et al.
Journal of Neuroendocrinology, 2023, 35 (4), ⟨10.1111/jne.13262⟩
Article dans une revue hal-04489852 v1

Surgery of primary lung carcinoid tumors at metastatic stage: A national study from the French Group of Endocrine Tumors ( GTE ) and ENDOCAN‐RENATEN network

Lucie Duponchelle , Eric Baudin , Fabien Subtil , Christine Do Cao , Eric Dansin et al.
Journal of Neuroendocrinology, 2023, 35 (10), ⟨10.1111/jne.13331⟩
Article dans une revue hal-04489849 v1

Bevacizumab plus FOLFIRI after failure of platinum–etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial

Thomas Walter , Astrid Lievre , Romain Coriat , David Malka , Farid Elhajbi et al.
Lancet Oncology, 2023, 24 (3), pp.297-306. ⟨10.1016/s1470-2045(23)00001-3⟩
Article dans une revue hal-04489738 v1
Image document

Necrosis as a strong independent prognostic factor required in the implementation of pathological reporting for pancreatic adenocarcinoma resection specimens

Tanguy Fenouil , Pierre Marie Lavrut , Maud Rabeyrin , Mustapha Adham , Kayvan Mohkam et al.
Pathology - Research and Practice, 2023, 244, pp.154406. ⟨10.1016/j.prp.2023.154406⟩
Article dans une revue hal-04168612 v1

887O First multicentric randomized phase II trial investigating the antitumor efficacy of peptide receptor radionucleide therapy with 177Lutetium-Octreotate (OCLU) in unresectable progressive neuroendocrine pancreatic tumor: Results of the OCLURANDOM trial

E. Baudin , Thomas Walter , A. Beron , D. Smith , J. Hadoux et al.
Annals of Oncology, 2022, 33, pp.S954. ⟨10.1016/j.annonc.2022.07.1013⟩
Article dans une revue hal-04490313 v1

Characterising aggressive pulmonary carcinoids through integrative omics analysis within the lungNENomics Project

A. Sexton-Oates , A. Di Genova , L. Mangiante , C. Voegele , Séverine Tabone-Eglinger et al.
Journal of Thoracic Oncology, 2022, 17 (9), pp.S45-S46
Article dans une revue cea-04352533 v1

<sup>18</sup>F-DOPA PET/CT at the Forefront of Initial or Presurgical Evaluation of Small-Intestine Neuroendocrine Tumors

Eric Ouvrard , Louis de Mestier , Caroline Boursier , Boumediene Lachachi , Nicolas Sahakian et al.
J.Nucl.Med., 2022, 63 (12), pp.1865-1870. ⟨10.2967/jnumed.122.263984⟩
Article dans une revue hal-03954228 v1

Response to systemic treatments in advanced fibrolamellar carcinoma: A French multicenter retrospective cohort of the AGEO.

Xixi Ye-Tran , Mohamed Bouattour , Audrey Perret , Anthony Turpin , Thomas Walter et al.
Journal of Clinical Oncology, 2022, 40 (16_suppl), pp.e16194-e16194. ⟨10.1200/JCO.2022.40.16_suppl.e16194⟩
Article dans une revue hal-04489869 v1

Healthcare cost by primary tumour, functioning status and treatment among patients with metastatic neuroendocrine tumours: The LyREMeNET study

Marine Perrier , Stéphanie Polazzi , Annie Lemelin , Violaine Fernandez , Stéphanie Labonne et al.
Journal of Neuroendocrinology, 2022, 34 (4), ⟨10.1111/jne.13092⟩
Article dans une revue hal-04151010 v1
Image document

Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their Disease

Clément Mennetrey , Maëlle Le Bras , Aurélie Bando-Delaunay , Laure Al-Mansour , Magalie Haissaguerre et al.
Journal of Clinical Endocrinology and Metabolism, 2022, 107 (5), pp.e2056-e2064. ⟨10.1210/clinem/dgab891⟩
Article dans une revue hal-03662789 v1

An International Registry of Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Frederic Mercier , Guillaume Passot , Pierre‐emmanuel Bonnot , Peter Cashin , Wim Ceelen et al.
World Journal of Surgery, 2022, 46 (6), pp.1336-1343. ⟨10.1007/s00268-022-06498-w⟩
Article dans une revue hal-04490255 v1

Second-Line Treatment and Prognostic Factors in Neuroendocrine Carcinoma.

Julien Hadoux , Thomas Walter , Christina Kanaan , Ségolène Hescot , Vincent Hautefeuille et al.
Endocrine-Related Cancer, 2022, 29 (10), p.569-580. ⟨10.1530/ERC-22-0102⟩
Article dans une revue hal-03746086 v1

Diagnostic endoscopic submucosal dissection for colorectal lesions with suspected deep invasion

Adrien Patenotte , Clara Yzet , Timothée Wallenhorst , Fabien Subtil , Sarah Leblanc et al.
Endoscopy, 2022, 55 (02), pp.192-197. ⟨10.1055/a-1866-8080⟩
Article dans une revue hal-04500038 v1
Image document

Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours: An international double-blind, placebo-controlled randomised phase II trial – Prodige 31 REMINET: An FFCD study

Côme Lepage , J-M. Phelip , Astrid Lièvre , Karine Le Malicot , L Dahan et al.
European Journal of Cancer, 2022, 175, pp.31-40. ⟨10.1016/j.ejca.2022.07.033⟩
Article dans une revue hal-03810530 v1

Prognosis and chemosensitivity of non-colorectal alimentary tract cancers with microsatellite instability

Claire Boyer , David Sefrioui , Romain Cohen , Romain Chautard , Marine Perrier et al.
Digestive and Liver Disease, 2022, ⟨10.1016/j.dld.2022.03.011⟩
Article dans une revue hal-03731980 v1

Efficacy of EUS-guided hepaticogastrostomy in prolonging survival of patients with perihilar cholangiocarcinoma

Armelle Schoch , Andrea Lisotti , Thomas Walter , Fabien Fumex , Sarah Leblanc et al.
Endoscopic Ultrasound, 2022, 11 (6), pp.487. ⟨10.4103/eus-d-22-00014⟩
Article dans une revue hal-04490222 v1
Image document

Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for small bowel neuroendocrine tumors with peritoneal metastasis

Roy Hajjar , Frederic Mercier , Guillaume Passot , Arnaud Pasquer , Maximiliano Gelli et al.
EJSO - European Journal of Surgical Oncology, 2022, 48 (7), pp.1626-1630. ⟨10.1016/j.ejso.2022.03.019⟩
Article dans une revue hal-04490265 v1

Desmoid tumors located in the abdomen or associated with adenomatous polyposis: French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)

Nicolas Benech , Sylvie Bonvalot , Armelle Dufresne , Afshin Gangi , Cécile Le Péchoux et al.
Digestive and Liver Disease, 2022, 54 (6), pp.737-746. ⟨10.1016/j.dld.2022.03.004⟩
Article dans une revue hal-03925724 v1

Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine Tumors

Paul Girot , Eric Baudin , Hélène Senellart , Nadia Bouarioua , Olivia Hentic et al.
Neuroendocrinology, 2022, 112 (6), pp.537-546. ⟨10.1159/000518650⟩
Article dans une revue hal-04490284 v1

Transcatheter Pulmonary Valve Implantation in Carcinoid Heart Disease

M. Flagiello , M. Pozzi , L. Francois , A. Al Harthy , J. Forestier et al.
Cardiovascular Revascularization Medicine, 2022, 40s, pp.130-134. ⟨10.1016/j.carrev.2021.12.027⟩
Article dans une revue inserm-03831063 v1

Life expectancy and likelihood of surgery in multiple endocrine neoplasia type 1: AFCE and GTE cohort study

Sébastien Gaujoux , Guillaume Martin , Eric Mirallié , Nicolas Regenet , Maëlle Le Bras et al.
British Journal of Surgery, 2022, 109 (9), pp.872-879. ⟨10.1093/bjs/znac006⟩
Article dans une revue hal-03883938 v1
Image document

Structural and Socio-Spatial Determinants Influencing Care and Survival of Patients with a Pancreatic Adenocarcinoma: Results of the PANDAURA Cohort

Gaël Roth , Yohan Fayet , Sakina Benmameche-Medjahed , Françoise Ducimetière , Amandine Charreton et al.
Cancers, 2022, 14 (21), pp.5413. ⟨10.3390/cancers14215413⟩
Article dans une revue hal-04490226 v1

Management of neuroendocrine neoplasms: conformity with guidelines in and outside a center of excellence

Carole Morin , Keo-Morakort Benedetto , Agathe Deville , Laurent Milot , Aurélie Theillaumas et al.
Endocrine Connections, 2022, 11 (6), ⟨10.1530/EC-22-0097⟩
Article dans une revue hal-04490245 v1
Image document

FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown origin

Julien Hadoux , Pauline Afchain , Thomas Walter , David Tougeron , Vincent Hautefeuille et al.
Digestive and Liver Disease, 2021, 53 (7), pp.824-829. ⟨10.1016/j.dld.2021.04.016⟩
Article dans une revue hal-03333521 v1

cfDNA in pancreatic neuroendocrine carcinoma management with Cushing’s syndrome

Laura Gerard , David Barthelemy , Arnaud Gauthier , Valerie Hervieu , Jonathan Lopez et al.
Endocrine Oncology, 2021, 1 (1), pp.K1-K6. ⟨10.1530/eo-21-0012⟩
Article dans une revue hal-04492472 v1
Image document

Issues and limitations of available biomarkers for fluoropyrimidine-based chemotherapy toxicity, a narrative review of the literature

K. Hodroj , D. Barthelemy , J.-C. Lega , G. Grenet , M.-C. Gagnieu et al.
ESMO Open, 2021, 6 (3), pp.100125. ⟨10.1016/j.esmoop.2021.100125⟩
Article dans une revue hal-04492195 v1

Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first‐line treatment in patients with metastatic pancreatic adenocarcinoma ( GATE 1)

Eric Assenat , Laurent Mineur , Caroline Mollevi , Evelyne Lopez-Crapez , Catherine Lombard-Bohas et al.
International Journal of Cancer, 2021, 148 (3), pp.682-691. ⟨10.1002/ijc.33225⟩
Article dans une revue hal-03670041 v1

Endoscopic ultrasound efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French study

Stephanie Morgant , Pascal Artru , Ammar Oudjit , Nelson Lourenco , Arnaud Pasquer et al.
Annals of translational medicine, 2021, 9 (1), pp.50-50. ⟨10.21037/atm-20-3474⟩
Article dans une revue hal-04492172 v1

Plasmatic and Urinary 5-Hydroxyindolacetic Acid Measurements in Patients With Midgut Neuroendocrine Tumors: A GTE Study

Louis de Mestier , Frédérique Savagner , Hedia Brixi , Christine Do Cao , Sophie Dominguez-Tinajero et al.
Journal of Clinical Endocrinology and Metabolism, 2021, 106 (4), pp.e1673-e1682. ⟨10.1210/clinem/dgaa924⟩
Article dans une revue hal-03287271 v1

Alkylating agent rechallenge in metastatic pancreatic neuroendocrine tumors

Ophélie de Rycke , Thomas Walter , Marine Perrier , Olivia Hentic , Catherine Lombard-Bohas et al.
Endocrine-Related Cancer, 2021, 28 (7), pp.457-466. ⟨10.1530/erc-21-0034⟩
Article dans une revue hal-04492482 v1

Endoscopic resection of Barrett's adenocarcinoma: Intramucosal and low‐risk tumours are not associated with lymph node metastases

Nicolas Benech , Jean Marc O'Brien , Maximilien Barret , Jéremie Jacques , Gabriel Rahmi et al.
United European Gastroenterology Journal, 2021, 9 (3), pp.362-369. ⟨10.1177/2050640620958903⟩
Article dans une revue hal-04470221 v1

Value of a patient-reported-outcome measure of carcinoid syndrome symptoms

Juliette Maurel , Rosine Guimbaud , Thierry Lecomte , Astrid Lièvre , Vincent Hautefeuille et al.
European Journal of Endocrinology, 2021, 184 (5), pp.711-722. ⟨10.1530/EJE-20-1138⟩
Article dans une revue hal-04179679 v1
Image document

Impact of the First Wave of the COVID-19 Pandemic on the Lyon University Hospital Cancer Institute (IC-HCL)

Anne-Sophie Belmont , Christophe Sajous , Amandine Bruyas , Sara Calattini , Stéphanie Cartalat et al.
Cancers, 2021, 14 (1), pp.29. ⟨10.3390/cancers14010029⟩
Article dans une revue hal-04490309 v1
Image document

Management of Patients with Pancreatic Ductal Adenocarcinoma in the Real-Life Setting: Lessons from the French National Hospital Database

Christelle de la Fouchardière , Mustapha Adham , Anne-Marie Marion-Audibert , Antoine Duclos , Claude Darcha et al.
Cancers, 2021, 13 (14), pp.3515. ⟨10.3390/cancers13143515⟩
Article dans une revue hal-04492495 v1
Image document

Targeting netrin‐3 in small cell lung cancer and neuroblastoma

Shan Jiang , Mathieu Richaud , Pauline Vieugué , Nicolas Rama , Jean‐guy Delcros et al.
EMBO Molecular Medicine, 2021, 13 (4), ⟨10.15252/emmm.202012878⟩
Article dans une revue hal-03410529 v1
Image document

Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant?

Melissa Frizziero , Alice Durand , Rodrigo Taboada , Elisa Zaninotto , Claudio Luchini et al.
Cancers, 2021, 13 (16), pp.4152. ⟨10.3390/cancers13164152⟩
Article dans une revue hal-04492480 v1
Image document

Principles of Surgical Management of Small Intestinal NET

Arnaud Pasquer , Thomas Walter , Laurent Milot , Valérie Hervieu , Gilles Poncet
Cancers, 2021, 13 (21), pp.5473. ⟨10.3390/cancers13215473⟩
Article dans une revue hal-04492163 v1
Image document

Efficacy of treatments for VIPoma: A GTE multicentric series

Mathias Brugel , Thomas Walter , Bernard Goichot , Denis Smith , Côme Lepage et al.
Pancreatology, 2021, 21 (8), pp.1531-1539. ⟨10.1016/j.pan.2021.08.001⟩
Article dans une revue hal-04492502 v1
Image document

Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network

Julien Hadoux , Christina Kanaan , Alice Durand , Segolene Hescot , Vincent Hautefeuille et al.
European journal of cancer, 2021, 152, pp.100-115. ⟨10.1016/j.ejca.2021.04.030⟩
Article dans une revue hal-03600262 v1

Management and Prognosis of Localized Duodenal Neuroendocrine Neoplasms

Servane Gay-Chevallier , Louis de Mestier , Julie Perinel , Julien Forestier , Valérie Hervieu et al.
Neuroendocrinology, 2021, 111 (8), pp.718-727. ⟨10.1159/000508102⟩
Article dans une revue hal-04179693 v1
Image document

Post first-line dacarbazine or temozolomide in neuroendocrine carcinoma

Thomas Couronne , Paul Girot , Julien Hadoux , Thierry Lecomte , Alice Durand et al.
Endocrine Connections, 2020, 9 (6), pp.498-505. ⟨10.1530/ec-20-0192⟩
Article dans une revue hal-04492751 v1

Endoscopic characterization of rectal neuroendocrine tumors with virtual chromoendoscopy: differences between benign and malignant lesions

Florian Veyre , Thomas Lambin , Caroline Fine , Tanguy Fenouil , Florian Rostain et al.
Endoscopy, 2020, 53 (06), pp.E215-E216. ⟨10.1055/a-1244-9526⟩
Article dans une revue hal-04491996 v1
Image document

Chemotherapy in resected neuroendocrine carcinomas of the digestive

Anna Pellat , Thomas Walter , Jeremy Augustin , Vincent Hautefeuille , Olivia Hentic et al.
Neuroendocrinology, 2020, 110 (5), pp.404-412. ⟨10.1159/000502825⟩
Article dans une revue hal-02996214 v1

Endoscopic ultrasound-guided gastrostomy to avoid interposed digestive loop is effective when lack of transillumination prevents percutaneous approach

Juliette Maurel , Gaspard Bertrand , Florian Beoletto , Thierry Ponchon , Thomas Walter et al.
Endoscopy, 2020, 52 (11), pp.E402-E403. ⟨10.1055/a-1149-1224⟩
Article dans une revue hal-04493508 v1

ctDNA in neuroendocrine carcinoma of gastroenteropancreatic origin or of unknown primary: the CIRCAN-NEC pilot study

Laura Gerard , Jessica Garcia , Arnaud Gauthier , Jonathan Lopez , Alice Durand et al.
Neuroendocrinology, In press, ⟨10.1159/000512502⟩
Article dans une revue hal-02999436 v1

Cost-effectiveness of Lutetium [ 177 Lu] oxodotreotide versus best supportive care with octreotide in patients with midgut neuroendocrine tumors in France

O. Leeuwenkamp , J. Smith-Palmer , R. Ortiz , A. Werner , W. Valentine et al.
Journal of Medical Economics, 2020, 23 (12), pp.1534-1541. ⟨10.1080/13696998.2020.1830286⟩
Article dans une revue hal-04492707 v1
Image document

Metformin and everolimus in neuroendocrine tumours: A synergic effect?

Lucia Hue-Fontaine , Annie Lemelin , Julien Forestier , Gerald Raverot , Laurent Milot et al.
Clinics and Research in Hepatology and Gastroenterology, 2020, 44, pp.954 - 960. ⟨10.1016/j.clinre.2020.02.011⟩
Article dans une revue hal-03492643 v1

Risk of neoplastic change in large gastric hyperplastic polyps and recurrence after endoscopic resection

Emmanuel Forté , Bérénice Petit , Thomas Walter , Vincent Lépilliez , Geoffroy Vanbiervliet et al.
Endoscopy, 2020, 52 (06), pp.444-453. ⟨10.1055/a-1117-3166⟩
Article dans une revue hal-04179697 v1

Clinical usefulness of FDG-PET for management of well-differentiated digestive neuroendocrine tumors

Marine Perrier , Olivia Hentic , Thomas Walter , Christine Do Cao , Guillaume Cadiot et al.
Digestive and Liver Disease, 2020, 52 (12), pp.1521-1524. ⟨10.1016/j.dld.2020.09.001⟩
Article dans une revue hal-04492690 v1

Unifocal versus multiple ileal neuroendocrine tumors location: an embryological origin

Maroin Kalifi , Thomas Walter , Laurent Milot , Valérie Hervieu , Ingrid Millot et al.
Neuroendocrinology, In press, ⟨10.1159/000511849⟩
Article dans une revue hal-02999432 v1
Image document

Systematic review and network meta-analyses of third-line treatments for metastatic colorectal cancer

Thomas Walter , Neil Hawkins , Richard Pollock , Fabien Colaone , Suki Shergill et al.
Journal of Cancer Research and Clinical Oncology, 2020, 146 (10), pp.2575-2587. ⟨10.1007/s00432-020-03315-6⟩
Article dans une revue hal-04492656 v1

Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)

Louis de Mestier , Come Lepage , Eric Baudin , Romain Coriat , Frédéric Courbon et al.
Digestive and Liver Disease, 2020, 52 (5), pp.473-492. ⟨10.1016/j.dld.2020.02.011⟩
Article dans une revue hal-04492748 v1

Extrapulmonary poorly differentiated NECs, including molecular and immune aspects

Mairéad Mcnamara , Jean-Yves Scoazec , Thomas Walter
Endocrine-Related Cancer, 2020, 27 (7), pp.R219-R238. ⟨10.1530/erc-19-0483⟩
Article dans une revue hal-04493496 v1
Image document

Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor

Louis de Mestier , Thomas Walter , Camille Evrard , Paul de Boissieu , Olivia Hentic et al.
Neuroendocrinology, 2020, 110 (1-2), pp.83-91. ⟨10.1159/000500862⟩
Article dans une revue hal-04492743 v1

Prospective comparison of whole-body MRI with diffusion-weighted and conventional imaging for the follow-up of neuroendocrine tumors

Maximilien Minon , Clothilde Soriano , David Morland , Thomas Walter , Côme Lepage et al.
Endocrine, 2020, 67, pp.243-251. ⟨10.1007/s12020-019-02095-5⟩
Article dans une revue hal-02478376 v1

Differential diagnosis of diarrhoea in patients with neuroendocrine tumours: A systematic review

Mohid Khan , Thomas Walter , Amy Buchanan-Hughes , Emma Worthington , Lucie Keeber et al.
World Journal of Gastroenterology, 2020, 26 (30), pp.4537-4556. ⟨10.3748/wjg.v26.i30.4537⟩
Article dans une revue hal-04492712 v1

Diagnostic endoscopic submucosal dissection with targeted tunnel to reach the suspect area first in order to diagnose muscular invasion and differentiate T1b from T2 cancers

Camille Meunier , Jérémie Jacques , Jérôme Rivory , Thomas Lambin , Thomas Walter et al.
Endoscopy, 2020, 53 (08), pp.870-871. ⟨10.1055/a-1268-7057⟩
Article dans une revue hal-04470335 v1

Elderly Patients with Metastatic Neuroendocrine Tumors Are Undertreated and Have Shorter Survival: The LyREMeNET Study

Annie Lemelin , Delphine Maucort-Boulch , Elisabeth Castel-Kremer , Julien Forestier , Valérie Hervieu et al.
Neuroendocrinology, 2020, 110 (7-8), pp.653-661. ⟨10.1159/000503901⟩
Article dans une revue hal-04151916 v1
Image document

Endoscopic, transanal, laparoscopic, and transabdominal management of rectal neuroendocrine tumors

Louis de Mestier , Diane Lorenzo , Caroline Fine , Jérôme Cros , Olivia Hentic et al.
Best Practice and Research: Clinical Endocrinology and Metabolism, 2019, 33, pp.101293 -. ⟨10.1016/j.beem.2019.101293⟩
Article dans une revue hal-03489062 v1
Image document

Prognostic and predictive value of nuclear imaging in endocrine oncology

Giorgio Treglia , Bernard Goichot , Luca Giovanella , Elif Hindié , Abhishek Jha et al.
Endocrine, 2019, 67 (1), pp.9-19. ⟨10.1007/s12020-019-02131-4⟩
Article dans une revue hal-04492687 v1
Image document

Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres

Melissa Frizziero , Xin Wang , Bipasha Chakrabarty , Alexa Childs , Tu Luong et al.
World Journal of Gastroenterology, 2019, 25 (39), pp.5991-6005. ⟨10.3748/wjg.v25.i39.5991⟩
Article dans une revue hal-04493932 v1

Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses

Louis de Mestier , Thomas Walter , Hedia Brixi , Camille Evrard , Jean-Louis Legoux et al.
Neuroendocrinology, 2019, 108 (4), pp.343-353. ⟨10.1159/000498887⟩
Article dans une revue hal-04493972 v1
Image document

Evaluation of a strategy using pretherapeutic fiducial marker placement to avoid missing liver metastases

V. Kepenekian , A. Muller , P. Valette , P. Rousset , M. Chauvenet et al.
BJS Open, 2019, 3 (3), pp.344-353. ⟨10.1002/bjs5.50140⟩
Article dans une revue hal-04493892 v1
Image document

Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors

Patrick Robelin , Julien Hadoux , Julien Forestier , David Planchard , Valérie Hervieu et al.
Journal of Thoracic Oncology, 2019, 14, pp.993 - 1002. ⟨10.1016/j.jtho.2019.02.002⟩
Article dans une revue hal-03484938 v1
Image document

Nonampullary duodenal subepithelial neuroendocrine tumor removed R0 by endoscopic submucosal dissection with double clips and rubber band traction

Borathchakra Oung , Thomas Walter , Valérie Hervieu , Jérémie Jacques , Mathieu Pioche
VideoGIE, 2019, 4 (12), pp.570-573. ⟨10.1016/j.vgie.2019.08.006⟩
Article dans une revue hal-04493877 v1

Endoscopic management of 345 small rectal neuroendocrine tumours: A national study from the French group of endocrine tumours (GTE)

Caroline Fine , Guillaume Roquin , Eric Terrebonne , Thierry Lecomte , Romain Coriat et al.
United European Gastroenterology Journal, 2019, 7 (8), pp.1102-1112. ⟨10.1177/2050640619861883⟩
Article dans une revue hal-02549178 v1

Neuropilin‐2 contributes to tumor progression in preclinical models of small intestinal neuroendocrine tumors

Julien Bollard , Céline Patte , Kristina Radkova , Patrick Massoma , Laurence Chardon et al.
Journal of Pathology, 2019, 249 (3), pp.343-355. ⟨10.1002/path.5321⟩
Article dans une revue hal-04653929 v1
Image document

Metabolomics of Small Intestine Neuroendocrine Tumors and Related Hepatic Metastases

Alessio Imperiale , Gilles Poncet , Pietro Addeo , Elisa Ruhland , Colette Roche et al.
Metabolites, 2019, 9 (12), pp.300. ⟨10.3390/metabo9120300⟩
Article dans une revue hal-02923574 v1

Everolimus after hepatic arterial embolisation therapy of metastases from gastrointestinal neuroendocrine tumours: The FFCD 1104-EVACEL-GTE phase II study

Thomas Walter , Come Lepage , Romain Coriat , Emilie Barbier , Guillaume Cadiot et al.
European Journal of Cancer, 2019, 123, pp.92-100. ⟨10.1016/j.ejca.2019.09.021⟩
Article dans une revue hal-04493861 v1
Image document

O6-methylguanine-DNA methyltransferase (MGMT) status in neuroendocrine tumors: a randomized phase II study (MGMT-NET)

Annie Lemelin , Marc Barritault , Valérie Hervieu , Léa Payen , Julien Péron et al.
Digestive and Liver Disease, 2019, 51, pp.595 - 599. ⟨10.1016/j.dld.2019.02.001⟩
Article dans une revue hal-03486315 v1

Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors : A National Study from the French Group of Endocrine Tumors (GTE)

Bérénice Rault-Petit , Christine Do Cao , Serge Guyétant , Rosine Guimbaud , Vincent Rohmer et al.
Annals of Surgery, 2019, 270 (1), pp.165-171. ⟨10.1097/SLA.0000000000002736⟩
Article dans une revue hal-02547901 v1

Immunosuppressive regimen and risk for de novo malignancies after liver transplantation for alcoholic liver disease

Jérôme Dumortier , Delphine Maucort-Boulch , Domitille Poinsot , Elsa Thimonier , Christine Chambon-Augoyard et al.
Clinics and Research in Hepatology and Gastroenterology, 2018, 42 (5), pp.427-435. ⟨10.1016/j.clinre.2018.04.011⟩
Article dans une revue hal-04151948 v1

Narrow-band imaging detects synchronous oropharyngeal squamous carcinoma during treatment of an early esophageal squamous cell carcinoma

Alexander Katzarov , Alexandru Lupu , Jérémie Jacques , Jérôme Rivory , Florian Rostain et al.
Endoscopy, 2018, 50 (09), pp.E264-E266. ⟨10.1055/a-0640-2464⟩
Article dans une revue hal-04495732 v1
Image document

Computed tomography scan efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French study

Stephanie Morgant , Pascal Artru , Ammar Oudjit , Nelson Lourenco , Arnaud Pasquer et al.
Cancer Management and Research, 2018, Volume 10, pp.3825-3831. ⟨10.2147/cmar.S163141⟩
Article dans une revue hal-04493982 v1

Combinatorial Treatment with mTOR Inhibitors and Streptozotocin Leads to Synergistic In Vitro and In Vivo Antitumor Effects in Insulinoma Cells

Julien Bollard , Céline Patte , Patrick Massoma , Isabelle Goddard , Nicolas Gadot et al.
Molecular Cancer Therapeutics, 2018, 17 (1), pp.60-72. ⟨10.1158/1535-7163.MCT-17-0325⟩
Article dans une revue hal-04494066 v1
Image document

Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy)

Jessica Garcia , Julien Forestier , Eric Dusserre , Anne-Sophie Wozny , Florence Geiguer et al.
Oncotarget, 2018, 9 (30), pp.21122-21131. ⟨10.18632/oncotarget.24950⟩
Article dans une revue hal-04383088 v1

Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy)

Jessica Garcia , Julien Forestier , Eric Dusserre , Anne-Sophie Wozny , Florence Geiguer et al.
Oncotarget, 2018, 9 (30), pp.21122-21131. ⟨10.18632/oncotarget.24950⟩
Article dans une revue hal-03625758 v1

An onco-geriatric approach to select older patients for optimal treatments of pancreatic adenocarcinoma

Elisabeth Castel-Kremer , Solene de Talhouet , Anne-Laure Charlois , Emmanuelle Graillot , Xavier Chopin-Laly et al.
Journal of Geriatric Oncology, 2018, 9 (4), pp.373-381. ⟨10.1016/j.jgo.2018.03.007⟩
Article dans une revue hal-04494047 v1

Gastric neuroendocrine tumors display deep invasive features, with amorphous pit and irregular vascular pattern, using narrow-band imaging and magnification

Adrien Choné , Thomas Walter , Jérôme Rivory , Pierre-Marie Lavrut , Julien Forestier et al.
Endoscopy, 2018, 50 (08), pp.E199-E201. ⟨10.1055/a-0606-4792⟩
Article dans une revue hal-04494046 v1

Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41–BEVANEC randomized phase II study

Thomas Walter , David Malka , Olivia Hentic , Catherine Lombard-Bohas , Karine Le Malicot et al.
Digestive and Liver Disease, 2018, 50 (2), pp.195-198. ⟨10.1016/j.dld.2017.11.020⟩
Article dans une revue hal-01699411 v1

A motivational phone call improves participation to screening colonoscopy for those with a positive FIT in a national screening programme (NCT 03276091)

Clémentine Gandilhon , Patricia Soler-Michel , Léa Vecchiato , Claude Chaunier , Isabelle Fay et al.
Digestive and Liver Disease, 2018, 50 (12), pp.1309-1314. ⟨10.1016/j.dld.2018.08.007⟩
Article dans une revue hal-04493977 v1

Patient-reported tolerance in treatments approved in neuroendocrine tumors: A national survey from the French Group of Endocrine Tumors

Arnaud Plante , Eric Baudin , Christine Do Cao , Olivia Hentic , Olivier Dubreuil et al.
Clinics and Research in Hepatology and Gastroenterology, 2018, 42 (2), pp.153-159. ⟨10.1016/j.clinre.2017.10.003⟩
Article dans une revue hal-04495704 v1
Image document

Intraoperative carcinoid syndrome during small-bowel neuroendocrine tumour surgery

Myrtille Fouché , Yves Bouffard , Mary-Charlotte Le Goff , Johanne Prothet , François Malavieille et al.
Endocrine Connections, 2018, 7 (12), pp.1245-1250. ⟨10.1530/ec-18-0324⟩
Article dans une revue hal-04494027 v1

Clinical and Biomarker Evaluations of Sunitinib in Patients with Grade 3 Digestive Neuroendocrine Neoplasms

Anna Pellat , Chantal Dreyer , Camille Couffignal , Thomas Walter , Catherine Lombard-Bohas et al.
Neuroendocrinology, 2018, 107 (1), pp.24-31. ⟨10.1159/000487237⟩
Article dans une revue hal-04495727 v1

Treatment of metastatic pancreatic neuroendocrine tumors: relevance of ENETS 2016 guidelines

Margaux Foulfoin , Emmanuelle Graillot , Mustapha Adham , Pascal Rousset , Julien Forestier et al.
Endocrine-Related Cancer, 2017, 24 (2), pp.71-81. ⟨10.1530/erc-16-0464⟩
Article dans une revue hal-04494085 v1

Chemotherapy for Well-Differentiated Pancreatic Neuroendocrine Tumours with a Ki-67 Index ≥10%: Is There a More Effective Antitumour Regimen? A Retrospective Multicentre Study of the French Group of Endocrine Tumours (GTE)

Guillaume Roquin , Éric Baudin , Catherine Lombard-Bohas , Guillaume Cadiot , Sophie Dominguez et al.
Neuroendocrinology, 2017, 106 (1), pp.38-46. ⟨10.1159/000457955⟩
Article dans une revue hal-02451453 v1

Survival and prognostic factors after adjuvant 131iodine-labeled lipiodol for hepatocellular carcinoma: a retrospective analysis of 106 patients over 20 years

Jonathan Olesinski , François Mithieux , Olivier Guillaud , Marie-Noëlle Hilleret , Catherine Lombard-Bohas et al.
Annals of Nuclear Medicine, 2017, 31 (5), pp.379-389. ⟨10.1007/s12149-017-1165-4⟩
Article dans une revue hal-04173123 v1
Image document

Management of gastric neuro-endocrine tumours in a large French national cohort (GTE).

Sylvain Manfredi , Thomas Walter , Eric Baudin , Philippe Ruszniewski , Thierry Lecomte et al.
Endocrine, 2017, 57 (3), pp.504-511. ⟨10.1007/s12020-017-1355-9⟩
Article dans une revue hal-01576810 v1

Management of desmoid tumours: A large national database of familial adenomatous patients shows a link to colectomy modalities and low efficacy of medical treatments

Thomas Walter , C Zhenzhen Wang , O Guillaud , E Cotte , A Pasquer et al.
United European Gastroenterology Journal, 2017, 5 (5), pp.735-741. ⟨10.1177/2050640616678150⟩
Article dans une revue hal-04495896 v1

Maintaining quality of life for patients with neuroendocrine tumours

Thomas Walter
Lancet Oncology, 2017, 18 (10), pp.1299-1300. ⟨10.1016/s1470-2045(17)30618-6⟩
Article dans une revue hal-04495910 v1
Image document

Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine Carcinomas

Angela Lamarca , Thomas Walter , Marianne Pavel , Ivan Borbath , Patricia Freis et al.
JNCI: Journal of the National Cancer Institute, 2017, 109 (5), pp.djw277. ⟨10.1093/jnci/djw277⟩
Article dans une revue hal-04495933 v1

Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort

T. Walter , T Tougeron , Emmanuel Baudin , K. Le Malicot , T. Lecomte et al.
European Journal of Cancer, 2017, 79, pp.158 - 165. ⟨10.1016/j.ejca.2017.04.009⟩
Article dans une revue hal-01609152 v1

Desmoid Tumors and Celecoxib with Sorafenib

Nicolas Benech , Thomas Walter , Jean-Christophe Saurin
New England Journal of Medicine, 2017, 376 (26), pp.2595-2597. ⟨10.1056/NEJMc1702562⟩
Article dans une revue hal-04495950 v1

In Reply

Romain Coriat , Benoît Terris , Thomas Walter
Oncologist, 2017, 22 (3), pp.359-360. ⟨10.1634/theoncologist.2016-0393⟩
Article dans une revue hal-04495937 v1
Image document

mTOR inhibitors activate PERK signaling and favor viability of gastrointestinal neuroendocrine cell lines

Patricia Freis , Julien Bollard , Justine Lebeau , Patrick Massoma , Joëlle Fauvre et al.
Oncotarget, 2017, 8 (13), pp.20974-20987. ⟨10.18632/oncotarget.15469⟩
Article dans une revue hal-02379643 v1

Evaluating lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours

Come Lepage , Laetitia Dahan , Nadia Bouarioua , Christos Toumpanakis , Jean-Louis Legoux et al.
Digestive and Liver Disease, 2017, 49 (5), pp.568 - 571. ⟨10.1016/j.dld.2017.02.004⟩
Article dans une revue hal-01599909 v1
Image document

Prognostic factors in neuroendocrine carcinoma: biological markers are more useful than histomorphological markers

Patricia Freis , Emmanuelle Graillot , Pascal Rousset , Valérie Hervieu , Laurence Chardon et al.
Scientific Reports, 2017, 7 (1), pp.40609. ⟨10.1038/srep40609⟩
Article dans une revue hal-04500093 v1

Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study

Davide Campana , Thomas Walter , Sara Pusceddu , Fabio Gelsomino , Emmanuelle Graillot et al.
Endocrine, 2017, 60 (3), pp.490-498. ⟨10.1007/s12020-017-1474-3⟩
Article dans une revue hal-04494061 v1

Neuroendocrine tumors producing calcitonin: characteristics, prognosis and potential interest of calcitonin monitoring during follow-up

C. Nozieres , L. Chardon , Bernard Goichot , F. Borson-Chazot , V. Hervieu et al.
European Journal of Endocrinology, 2016, 174 (3), pp.335-41. ⟨10.1530/EJE-15-0917⟩
Article dans une revue hal-01850353 v1

Evaluation of the combination of oxaliplatin and 5-fluorouracil or gemcitabine in patients with sporadic metastatic pulmonary carcinoid tumors

Thomas Walter , D. Planchard , K. Bouledrak , J.Y. Scoazec , P.J. Souquet et al.
Lung Cancer, 2016, 96, pp.68-73. ⟨10.1016/j.lungcan.2016.03.018⟩
Article dans une revue hal-04495958 v1

Locally advanced pancreatic duct adenocarcinoma: pancreatectomy with planned arterial resection based on axial arterial encasement

J. Perinel , G. Nappo , M. El Bechwaty , Thomas Walter , V. Hervieu et al.
Langenbeck's Archives of Surgery, 2016, 401 (8), pp.1131-1142. ⟨10.1007/s00423-016-1488-y⟩
Article dans une revue hal-04496006 v1

Type 1 serrated polyposis represents a predominantly female disease with a high prevalence of dysplastic serrated adenomas, without germline mutation in MUTYH, APC , and PTEN genes

Marco Petronio , Stephane Pinson , Thomas Walter , Marie‐odile Joly , Valerie Hervieu et al.
United European Gastroenterology Journal, 2016, 4 (2), pp.305-313. ⟨10.1177/2050640615594939⟩
Article dans une revue hal-04495988 v1
Image document

Radiochemotherapy Versus Surgery in Nonmetastatic Anorectal Neuroendocrine Carcinoma

Bertrand Brieau , Céline Lepère , Thomas Walter , Thierry Lecomte , Rosine Guimbaud et al.
Medicine, 2015, 94 (42), pp.e1864. ⟨10.1097/MD.0000000000001864⟩
Article dans une revue hal-01301145 v1

Contrast-enhanced ultrasound after devascularisation of neuroendocrine liver metastases: functional and morphological evaluation

A. Guibal , T. Lefort , L. Chardon , N. Benslama , S. Mule et al.
European Radiology, 2013, 23 (3), pp.805--815. ⟨10.1007/s00330-012-2646-4⟩
Article dans une revue istex hal-01918695 v1

Evaluation of shearwave elastography for the characterisation of focal liver lesions on ultrasound

A. Guibal , C. Boularan , M. Bruce , M. Vallin , F. Pilleul et al.
European Radiology, 2013, 23 (4), pp.1138--1149. ⟨10.1007/s00330-012-2692-y⟩
Article dans une revue istex hal-01918694 v1

Antitumor Effect of Everolimus in Preclinical Models of High Grade Gastroenteropancreatic Neuroendocrine Carcinomas.

Julien Bollard , Christophe Couderc , Martine Blanc , Gilles Poncet , Florian Lepinasse et al.
Neuroendocrinology, 2013, epub ahead of print. ⟨10.1159/000347063⟩
Article dans une revue hal-00790198 v1

Obstructing minute primary endocrine tumor of the main pancreatic duct: diagnostic relevance of endoscopic ultrasonography

R. Gincul , T. Walter , B. Napoleon , C. Lombard-Bohas , C. Partensky et al.
Pancreas, 2012, 41 (1), pp.164--165
Article dans une revue hal-01918698 v1

Correlation and agreement between contrast-enhanced ultrasonography and perfusion computed tomography for assessment of liver metastases from endocrine tumors: normalization enhances correlation

T. Lefort , F. Pilleul , S. Mule , S. L. Bridal , F. Frouin et al.
Ultrasound in Medicine & Biology, 2012, 38 (6), pp.953--961
Article dans une revue hal-01918702 v1

F-18-FLT and F-18-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours

F. Giammarile , C. Billotey , C. Lombard-Bohas , D. Le Bars , C. Bournaud et al.
Nuclear Medicine Communications, 2011, 32, pp.91-97
Article dans une revue hal-02299115 v1

Neuroendocrine tumors of Meckel's diverticulum: lessons from a single institution study of eight cases

G. Poncet , V. Hervieu , T. Walter , F. Lepinasse , L. Chardon et al.
Journal of Gastrointestinal Surgery, 2011, 15 (1), pp.101--109
Article dans une revue hal-01918705 v1

Well-differentiated pancreatic islet cell carcinoma: Is there reversibility in mTOR inhibitor resistance?

Thomas Walter , Jean-Yves Scoazec , Christophe Couderc , Julien Forestier , Colette Roche et al.
Acta Oncologica, 2011, 50 (5), pp.731-2. ⟨10.3109/0284186X.2011.562919⟩
Article dans une revue hal-00710300 v1

Effects of somatostatin and octreotide on the interactions between neoplastic gastroenteropancreatic endocrine cells and endothelial cells: a comparison between in vitro and in vivo properties.

Thomas Walter , Juliette Hommell-Fontaine , Géraldine Gouysse , Céline Pourreyron , Mimoun Nejjari et al.
Neuroendocrinology, 2011, 94 (3), pp.200-8. ⟨10.1159/000328134⟩
Article dans une revue hal-00710320 v1

Primary neuroendocrine tumors of the main pancreatic duct: a rare entity.

Thomas Walter , Valérie Hervieu , Mustapha Adham , Rodica Gincul , Gilles Poncet et al.
Virchows Archiv, 2011, 458 (5), pp.537-46. ⟨10.1007/s00428-011-1067-0⟩
Article dans une revue istex hal-00713749 v1

Targeting the PI3K/mTOR pathway in murine endocrine cell lines: in vitro and in vivo effects on tumor cell growth.

Christophe Couderc , Gilles Poncet , Karine Villaume , Martine Blanc , Nicolas Gadot et al.
American Journal of Pathology, 2011, 178 (1), pp.336-44. ⟨10.1016/j.ajpath.2010.11.023⟩
Article dans une revue hal-00710288 v1

18F-FLT and 18F-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours.

Francesco Giammarile , Claire Billotey , Catherine Lombard-Bohas , Didier Le Bars , Claire Bournaud et al.
Nuclear Medicine Communications, 2011, 32 (2), pp.91-7. ⟨10.1097/MNM.0b013e3283412143⟩
Article dans une revue hal-00814028 v1

Transcatheter local thrombolysis in patients with extensive TIPS thrombosis

J. Dumortier , T. Walter , O. Guillaud , F. Pietu , M. Vallin et al.
Gastroenterol. Clin. Biol., 2010, 34 (12), pp.721--725
Article dans une revue hal-01918717 v1

TIPS thrombosis related to abdominal trauma

F. Pietu , T. Walter , O. Guillaud , F. Pilleul , J. Dumortier
European Journal of Gastroenterology & Hepatology, 2010, 22 (7), pp.883--885
Article dans une revue hal-01918719 v1

VEGF Secretion by Neuroendocrine Tumor Cells Is Inhibited by Octreotide and by Inhibitors of the PI3K/AKT/mTOR Pathway.

Karine Villaume , Martine Blanc , Géraldine Gouysse , Thomas R. Walter , Christophe Couderc et al.
Neuroendocrinology, 2010, epub ahead of print. ⟨10.1159/000289569⟩
Article dans une revue hal-00475083 v1

Evaluation of the combination 5-fluorouracil, dacarbazine, and epirubicin in patients with advanced well-differentiated neuroendocrine tumors

T. Walter , D. Bruneton , P. A. Cassier , V. Hervieu , F. Pilleul et al.
Clinical Colorectal Cancer, 2010, 9 (4), pp.248--254
Article dans une revue hal-01918720 v1

Gemcitabine and oxaliplatin combination chemotherapy for metastatic well-differentiated neuroendocrine carcinomas: a single-center experience.

Philippe A Cassier , Thomas R. Walter , Beatrice Eymard , Philippe Ardisson , Maurice Perol et al.
Cancer / Cancer (Phila), 2009, epub ahead of print. ⟨10.1002/cncr.24384⟩
Article dans une revue hal-00391942 v1

Angiogenesis and tumor progression in neuroendocrine digestive tumors.

Gilles Poncet , Karine Villaume , Thomas Walter , Céline Pourreyron , Aurélie Theillaumas et al.
Journal of Surgical Research, 2009, 154 (1), pp.68-77. ⟨10.1016/j.jss.2008.03.055⟩
Article dans une revue istex hal-00475688 v1
Image document

Human blood biomarkers of skeletal muscle atrophy

Coralie Delabrise , Julien Aniort , Cécile Polge , Agnès Claustre , Lydie Combaret et al.
Journées de la Société Française de Myologie 21ème Édition, Société Française de Myologie, Nov 2024, Clermont - Ferrand, France
Communication dans un congrès hal-04992128 v1

Etoposide-based rechallenge and second/third line treatments in patients with metastatic neuroendocrine carcinoma: Results from the multicenter RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network

Thomas Walter
19th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2022, Barcelona (ES), Spain. pp.111
Communication dans un congrès hal-04490282 v1

LBA46 Bevacizumab (B) plus FOLFIRI after failure of platinum-etoposide in patients (pts) with advanced neuroendocrine carcinoma (NEC): The PRODIGE 41-BEVANEC randomized phase II study

Thomas Walter , A. Lievre , R. Coriat , D. Malka , F. El Hajbi et al.
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, Sep 2022, Paris, France. pp.S1412, ⟨10.1016/j.annonc.2022.08.045⟩
Communication dans un congrès hal-04489922 v1

Characterisation, prognosis, and treatment of patients with locally advanced or metastatic thymic carcinoid tumor: A retrospective study of the French GTE-ENDOCAN RENATEN and RYTHMIC networks

Thomas Walter
19th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2022, Barcelona (ES), Spain. pp.73
Communication dans un congrès hal-04490299 v1

Antisecretory effect of oral targeted therapies in advanced functioning neuroendocrine tumors (the ASSET-NET study)

Thomas Walter
19th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2022, Barcelona (ES), Spain. pp.186
Communication dans un congrès hal-04490234 v1

Characterising aggressive pulmonary carcinoids through integrative omics analysis

Thomas Walter
19th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2022, Barcelona (ES), Spain. pp.29
Communication dans un congrès hal-04489996 v1

Surgical management of patients with sporadic Zollinger-Ellison Syndrome: An ACHBT and GTE study

Thomas Walter
19th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2022, Barcelona (ES), Spain. pp.195
Communication dans un congrès hal-04490290 v1

Cost of carcinoid syndrome (CS) In France: Analysis of the national health insurance database

Thomas Walter
18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Feb 2021, Virtual conference, Germany. pp.76
Communication dans un congrès hal-04492045 v1

LBA41 Nivolumab (nivo) ± ipilimumab (ipi) in pre-treated patients with advanced, refractory pulmonary or gastroenteropancreatic poorly differentiated neuroendocrine tumors (NECs) (GCO-001 NIPINEC)

N. Girard , J. Mazieres , J. Otto , H. Lena , C. Lepage et al.
Abstract Book of the ESMO Congress 2021, 16 – 21 September, Sep 2021, Paris, France. pp.S1318, ⟨10.1016/j.annonc.2021.08.2119⟩
Communication dans un congrès hal-04492251 v1

OPERA: Observational study of perception of information and quality of life (QoL) in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) starting Lanreotide Autogel (LAN)

Thomas Walter
18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Feb 2021, Virtual conference, Germany. pp.136
Communication dans un congrès hal-04492200 v1

Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumors - An international double-blind, placebo-controlled randomized phase 2. Prodige 31 REMINET. A FFCD study

Thomas Walter
18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Feb 2021, Virtual conference, Germany. pp.139
Communication dans un congrès hal-04492188 v1

Plasmatic and urinary 5-hydroxyindolacetic acid measurements in patients with midgut neuroendocrine tumors: A GTE study

Thomas Walter
18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Feb 2021, Virtual conference, Germany. pp.104
Communication dans un congrès hal-04492492 v1

Prognosis and the role of Rb expression in metastatic grade 3 neuroendocrine carcinoma (G3NEC), results from the multicenter retrospective RbNEC study

Thomas Walter
18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Feb 2021, Virtual conference, Germany. pp.107
Communication dans un congrès hal-04492213 v1

Dacarbazine- or Temozolomide-Based Chemotherapy in Metastatic Digestive Neuroendocrine Carcinomas in Post First-line Chemotherapy: A Retrospective Multicentric Study of the French Group of Endocrine Tumours (GTE)

Thomas Walter
17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Virtual conference, Germany. pp.(H08)
Communication dans un congrès hal-04493659 v1

Patient and Nurse Satisfaction with the New Lanreotide Autogel Pre-Filled Syringe in Neuroendocrine Tumors (NET): A Prospective Study (SONATE)

Thomas Walter
17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Virtual conference, Germany. pp.H30
Communication dans un congrès hal-04493487 v1

Impact of Small Cell (SC) versus (vs.) Non-Small Cell (nSC) Morphology on Outcomes of Patients (pts) with Extra-Pulmonary, Poorly Differentiated Neuroendocrine Carcinoma (EP-PD-NEC)

Thomas Walter
Abstracts of the 17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Barcelona (ES), Spain. pp.(J25)
Communication dans un congrès hal-04492643 v1

Differential Diagnosis (DDX) of Carcinoid Syndrome Diarrhea (CSD): A Systematic Literature Review (SLR)

Thomas Walter
12th Annual Multidisciplinary Neuroendocrine Tumor Medical Symposium of the North American Neuroendocrine Tumor Society, Oct 2019, Boston (MA), United States. pp.472
Communication dans un congrès hal-04493548 v1

OPERA: Observational Study of Perception of Information and Quality of Life in Patients with Gastroenteropancreatic NeuroEndocrine TumoRs Starting LAnreotide Autogel-Baseline Characteristics

Thomas Walter
17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Virtual conference, Germany. pp.(D23)
Communication dans un congrès hal-04493628 v1

The PanNENomics Project: A Call for an International Collaborative Effort Built on the Success of the LungNENomics Project

Thomas Walter
17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Virtual conference, Germany. pp.(C08)
Communication dans un congrès hal-04493635 v1

Efficacy of Alkylating Agent Re-challenge after Therapeutic Pause in Metastatic Pancreatic Neuroendocrine Tumors (PanNET)

Thomas Walter
17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Virtual conference, Germany. pp.(H11)
Communication dans un congrès hal-04493642 v1

A systematic review and exploratory network meta-analysis of third-line treatments for metastatic colorectal cancer

Thomas Walter
ISPOR 2020 HEOR: Advancing Evidence to Action, May 2020, Orlando (FL), United States. pp.S30
Communication dans un congrès hal-04492668 v1

Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses

Thomas Walter
16th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2019, Barcelona (ES), France. pp.(H07)
Communication dans un congrès hal-04495625 v1

The Effect of Carcinoid Syndrome Diarrhea (CSD) Interventions on Patient Experience Outcomes: A Systematic Literature Review (SLR)

Thomas Walter
16th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2019, Barcelone (ES), Spain. pp.(J15)
Communication dans un congrès hal-04493864 v1

Differential Diagnosis (DDx) of Carcinoid Syndrome Diarrhea (CSD): A Systematic Literature Review (SLR)

Thomas Walter
16th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2019, Barcelona (ES), Spain. pp.(J08)
Communication dans un congrès hal-04493888 v1

Temozolomide (TEM) vs Temozolomide-Capecitabine (CAP) in Advanced Pancreatic NET (pNET): A Multicenter Retrospective Analysis of 138 Patients Using a Propensity Score

Thomas Walter
6th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2019, Barcelona (ES), Spain. pp.(H08)
Communication dans un congrès hal-04495620 v1

Carcinoid heart disease (CHD): the CRUSOE-NETs, a prospective cohort study from the French group of endocrine tumours (GTE)

K. Dekeister Geoffroy , L. Francois , Thomas Walter , O. Hentic Dhome , A. Cachier et al.
44th ESMO Congress (ESMO 2019), Sep 2019, Barcelona (ES), Spain. pp.v196, ⟨10.1093/annonc/mdz245.007⟩
Communication dans un congrès hal-04493904 v1

Framework synthesis of qualitative and quantitative evidence to explore the differential diagnosis of diarrhea in neuroendocrine tumor patients

Thomas Walter
ISPOR 2019: Rapid. Disruptive. Innovative: A New Era in HEOR, May 2019, Nouvelle Orléans (LA), United States. pp.S265
Communication dans un congrès hal-04493855 v1

Endoscopic Management of 345 Small Rectal Neuroendocrine Tumours: A National Study from the French Group of Endocrine Tumours (GTE)

Thomas Walter
16th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2019, Barcelona (ES), Spain. pp.(G01)
Communication dans un congrès hal-04495616 v1

Everolimus after transarterial liver therapy of metastases from gastrointestinal neuroendocrine tumors: The FFCD 1104-EVACEL-GTE phase II study

Thomas Walter
43rd ESMO Congress (ESMO 2018), Mar 2018, Munich (Allemagne), Germany. pp.viii469
Communication dans un congrès hal-04495683 v1

Patient Survey Devoted to Characterizing Experience and Expectations of Patients with Neuroendocrine Tumors (NET)

Thomas Walter
15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelona (ES), Spain. pp.(D59)
Communication dans un congrès hal-04495692 v1

Perioperative Chemotherapy in Resectable Neuroendocrine Carcinomas of the Digestive Tract

Thomas Walter
15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2018, Barcelona (ES), Spain. pp.(H20)
Communication dans un congrès hal-04495718 v1

Treatment of Metastatic Pancreatic Neuroendocrine Tumors: Relevance of ENETS 2016 Guidelines

Thomas Walter
14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelone (ES), Spain. pp.(J6)
Communication dans un congrès hal-04500118 v1

Mixed adeno-neuroendocrine carcinoma (MANEC) of the gastroenteropancreatic (GEP) tract: A multicentre retrospective study

M. Frizziero , X. Wang , B. Chakrabarty , A. Childs , T.V. Luong et al.
42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid (ES), Spain. pp.155, ⟨10.1093/annonc/mdx368.038⟩
Communication dans un congrès hal-04500086 v1

Comparison of performances of three technologies for detection of RAS mutations in cfDNA (NGS strategy, BEAMing assay and ddPCR BioRAD assay)

J. Garcia , J. Forestier , E. Dusserre , C. Rodriguez-Lafrasse , V. Cheynet et al.
42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid (ES), Spain. pp.197, ⟨10.1093/annonc/mdx393.107⟩
Communication dans un congrès hal-04499713 v1

Intraoperative Carcinoid Syndrome during Small-Bowel NET Surgery: Description, Prevalence and Risk Factors

Thomas Walter
14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelona (ES), Spain. pp.(R6)
Communication dans un congrès hal-04504145 v1

Patient-Reported Preferences in Treatments Approved in Neuroendocrine Tumors: A National Survey from the French Group of Endocrine Tumors

Thomas Walter
14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelona (ES), Spain. pp.(R12)
Communication dans un congrès hal-04495920 v1

Implication of Neuropilin-2 in the Progression of Small Intestinal Neuroendocrine Tumors: Towards a Promising Therapeutic Target

Thomas Walter
14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelona (ES), Spain. pp.(A2)
Communication dans un congrès hal-04504139 v1

REMINET : A European, Multicenter, Phase II/III Randomized Double-Blind, Placebo-Controlled Study Evaluating Lanreotide As Maintenance Therapy after First-Line Treatment in Patients with Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors

C. Lepage , L. Dahan , J.-L. Legoux , K. Le Malicot , R. Guimbaud et al.
The 14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelone, Spain. pp.187 (J8)
Communication dans un congrès hal-01664217 v1

FFCD Prodige 31 Reminnet

Côme Lepage , L. Dahan , Jean-Louis Legoux , Karine Le Malicot , Rosine Guimbaud et al.
The 14th Annual ENETS Conference, Mar 2017, Barcelone, Spain. , 2017, ⟨10.13140/RG.2.2.35427.35368⟩
Poster de conférence hal-01578731 v1
Image document

MISE EN PLACE ET EVALUATION D'UNE ACTIVITE DE PHARMACIE CLINIQUE EN HOPITAL DE JOUR ONCOLOGIQUE

Fiona Malagutti , Rémi Faure , Thomas Walter , Julien Forestier , Catherine Lombard-Bohas et al.
Xémes Journées de la Société Française de Pharmacie Oncologique, Oct 2015, Nantes, France
Poster de conférence hal-01214190 v1